The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

DLA Piper LLP (US)

John Wellschlager

Tel:
Work 1 410 580 4281
Email:
DLA Piper LLP (US)

Work Department

Litigation

Position

Partner

Career

John Wellschlager represents public and private companies across multiple sectors in connection with class action, securities, product liability, and commercial litigation.

 

His litigation experience ranges from handling "bet the company" storms – encompassing shareholder class action claims, shareholder derivative claims, multi-district product liability claims, consumer fraud class actions, and internal and external investigations – to traditional commercial disputes. John has led internal investigations and reviews for companies in the health insurance, life insurance, and pharmaceutical sectors on issues ranging from FDA compliance to FCPA and other anti-corruption considerations. His clients include major pharmaceutical companies, banks and other financial institutions, various other public companies, and individuals.

Education

JD, University of Maryland; BA, Kenyon College


United States: Dispute resolution

Product liability, mass tort and class action: toxic tort - defense

Within: Product liability, mass tort and class action: toxic tort - defense

Jointly headed by Raymond Williams in Philadelphia and Christopher Young in San Diego, the product liability and mass torts practice at DLA Piper LLP (US) is primarily active in asbestos litigation. Led by Boston-based Matthew Holian and John Wellschlager in Baltimore, the team continues to act as national counsel for BASF Catalyst in asbestos litigation related to its predecessor Engelhard and recently won a summary judgment in favor of the client in Fields v Ford Motor Company. Porsche, Exxon Mobil and NJOY are also clients of the firm.

[back to top]


Back to index

Legal Developments by:
DLA Piper LLP (US)

  • Sentencing guidelines for corporate manslaughter

    In February 2010 the Sentencing Guidelines Council (the SGC) issued definitive guidelines to courts on imposing appropriate sentences for corporate manslaughter and health and safety offences causing death. The SGC states that fines imposed on companies found guilty of corporate manslaughter should not fall below £500,000, while fines in respect of health and safety offences that are a significant cause of death should be at least £100,000. Crucially, the SGC declined to provide for a fixed link between the imposed fine and the turnover or profitability of the offending company.

    - DLA Piper UK LLP

Legal Developments worldwide

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to